Related Experiment Video
Updated: Sep 8, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
Clemens Gangl1, Konstantin A Krychtiuk1, Robert Schoenbauer1
1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Abstract:
Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotropy. This article describes two cases of successful treatment of supraventricular and ventricular tachycardias with landiolol in critically ill patients.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias VII: Nursing Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers